These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


153 related items for PubMed ID: 19142421

  • 1. Quetiapine for the treatment of trichotillomania.
    Crescente Junior JA, Guzman CS, Tavares H.
    Braz J Psychiatry; 2008 Dec; 30(4):402. PubMed ID: 19142421
    [No Abstract] [Full Text] [Related]

  • 2. Olanzapine augmentation of fluoxetine in the treatment of trichotillomania.
    Potenza MN, Wasylink S, Epperson CN, McDougle CJ.
    Am J Psychiatry; 1998 Sep; 155(9):1299-300. PubMed ID: 9734562
    [No Abstract] [Full Text] [Related]

  • 3. An overview of trichotillomania and its response to treatment with quetiapine.
    Khouzam HR, Battista MA, Byers PE.
    Psychiatry; 2002 Sep; 65(3):261-70. PubMed ID: 12405081
    [Abstract] [Full Text] [Related]

  • 4. Quetiapine plus SSRI in treatment-resistant depression: possible mechanisms.
    Devarajan S, Ali J, Dursun SM.
    Psychopharmacology (Berl); 2006 Apr; 185(3):402-3. PubMed ID: 16538471
    [No Abstract] [Full Text] [Related]

  • 5. A double-blind, randomized, controlled trial of fluoxetine plus quetiapine or clomipramine versus fluoxetine plus placebo for obsessive-compulsive disorder.
    Diniz JB, Shavitt RG, Fossaluza V, Koran L, Pereira CA, Miguel EC.
    J Clin Psychopharmacol; 2011 Dec; 31(6):763-8. PubMed ID: 22020357
    [Abstract] [Full Text] [Related]

  • 6. Trichotillomania: a treatment overview.
    Voth D.
    J Pract Nurs; 2011 Dec; 56(4)-57(1)():34-7. PubMed ID: 17484394
    [No Abstract] [Full Text] [Related]

  • 7. A case of problematic internet use successfully treated with an SSRI-antipsychotic combination.
    Atmaca M.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 May 09; 31(4):961-2. PubMed ID: 17321659
    [No Abstract] [Full Text] [Related]

  • 8. Quetiapine-fluvoxamine combination during pregnancy and while breastfeeding.
    Gentile S.
    Arch Womens Ment Health; 2006 May 09; 9(3):158-9. PubMed ID: 16683078
    [No Abstract] [Full Text] [Related]

  • 9. Quetiapine addition in obsessive-compulsive disorder: is treatment outcome affected by type and dose of serotonin reuptake inhibitors?
    Denys D, Fineberg N, Carey PD, Stein DJ.
    Biol Psychiatry; 2007 Feb 01; 61(3):412-4. PubMed ID: 17241831
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A double-blind, randomized, placebo-controlled trial of quetiapine addition in patients with obsessive-compulsive disorder refractory to serotonin reuptake inhibitors.
    Denys D, de Geus F, van Megen HJ, Westenberg HG.
    J Clin Psychiatry; 2004 Aug 01; 65(8):1040-8. PubMed ID: 15323587
    [Abstract] [Full Text] [Related]

  • 16. A novel treatment option of bipolar depression with psychotic and catatonic features.
    Di Michele V, Bolino F.
    Gen Hosp Psychiatry; 2006 Aug 01; 28(4):364-5. PubMed ID: 16814640
    [No Abstract] [Full Text] [Related]

  • 17. Comparative efficacy and acceptability of drug treatments for bipolar depression: a multiple-treatments meta-analysis.
    Taylor DM, Cornelius V, Smith L, Young AH.
    Acta Psychiatr Scand; 2014 Dec 01; 130(6):452-69. PubMed ID: 25283309
    [Abstract] [Full Text] [Related]

  • 18. Quetiapine addition to serotonin reuptake inhibitor treatment in patients with treatment-refractory obsessive-compulsive disorder: an open-label study.
    Denys D, van Megen H, Westenberg H.
    J Clin Psychiatry; 2002 Aug 01; 63(8):700-3. PubMed ID: 12197450
    [Abstract] [Full Text] [Related]

  • 19. Acute and maintenance treatments for bipolar depression.
    Ketter TA.
    J Clin Psychiatry; 2014 Apr 01; 75(4):e10. PubMed ID: 24813411
    [Abstract] [Full Text] [Related]

  • 20. Quetiapine augmentation in obsessive-compulsive disorder resistant to serotonin reuptake inhibitors: an open-label study.
    Bogan AM, Koran LM, Chuong HW, Vapnik T, Bystritsky A.
    J Clin Psychiatry; 2005 Jan 01; 66(1):73-9. PubMed ID: 15669891
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.